{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"17.7","upperLimit":"32.1","value":"27.8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"VDT: VELCADE, Doxil and Low-dose Thalidomide"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Every 3 monthsntil the date of first documented progression or date of death from any cause, whichever came first","title":"Time to Disease Progression","type":"SECONDARY","unitOfMeasure":"months"}